The cardiovascular effects of ketamine in man
- 1 September 1976
- journal article
- Published by Wiley in Anaesthesia
- Vol. 31 (7) , 873-882
- https://doi.org/10.1111/j.1365-2044.1976.tb11898.x
Abstract
The arterial hypertension of ketamine is prevented by verapamil, a calcium ion antagonist. This indicates that ketamine is a direct myocardial stimulant acting by increasing the availability of calcium across the cell membranes of the myocardial and the Purkinjé systems. The positive chronotropic action of ketamine is not reversed by verapamil. Both the chronotropic and the inotropic effects of ketamine are prevented by halothane which acts partly by increased vagal tone and partly by what appears to be a verapamil-like depression of calcium availability. Ketamine blocks the reflex sympathetic response of the peripheral blood vessels to surgical stimuli. The site of the block within the sympathetic reflex arc has not been identified. It is not at the alpha adrenoceptor level. The clinical implications of the findings have been discussed.Keywords
This publication has 23 references indexed in Scilit:
- The cardiorespiratory effects of Althesin and ketamine.Anaesthesia, 1973
- Attempts to control the cardiostimulatory effect of ketamine in manAnaesthesia, 1972
- Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscleCardiovascular Research, 1972
- The Effect of Alpha-Adrenergic Blockade on the Cardiopulmonary Response to KetamineAnesthesia & Analgesia, 1971
- Alarming Reactions to Ketamine in Patients Taking Thyroid Medication—Treatment with PropranololAnesthesiology, 1971
- The Effect of Beta-Adrenergic Blockade on the Cardiopulmonary Response to KetamineAnesthesia & Analgesia, 1970
- Calcium exchange in cardiac muscle: A basic mechanism of drug actionAmerican Heart Journal, 1967
- ADRENALINE AND NORADRENALINE DURING ANÆSTHESIAAnaesthesia, 1953
- GENERAL ANAeSTHESIA AND CARDIAC INHIBITIONHeart, 1951